Research workbench
Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with D(TGTACA) and D(CGATCG)
Analyse Molecular structure of the halogenated anti-cancer drug iododoxorubicin… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 1IMR
- Type
- DNA
- Length
- 6 nucleotides
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- DNA (5'-D(*TP*GP*TP*AP*CP*A)-3')
- Ligands
- DM7
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') | dna | 6 | — | — |
Ligands and binding sites
- DM7 · 4'-deoxy-4'-iododoxorubicin · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 1IMR · Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 1IMR · PDBe 1IMR
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.